I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Neuzillet, C.
129
results:
Search for persons
X
Format
Online (129)
Mediatypes
Articles (Online) (61)
OpenAccess-fulltext (68)
Languages
english (121)
french (6)
Sorted by: Relevance
Sorted by: Year
?
1
294P Intrahepatic cholangiocarcinoma (iCCA) trends and trea..:
Delaye, M.
;
Grenier, B.
;
Lievre, A.
.
Annals of Oncology. 35 (2024) - p. S124 , 2024
Link:
https://doi.org/10.1016/..
?
2
Current practices and challenges in implementing precision ..:
Alsina, M.
;
Huerta, A.E.
;
Lordick, F.
...
ESMO Gastrointestinal Oncology. 5 (2024) - p. 100074 , 2024
Link:
https://doi.org/10.1016/..
?
3
Advances in the management of hepatobiliary and pancreatic ..:
Fulgenzi, C.
;
Garajová, I.
;
Moehler, M.
...
ESMO Gastrointestinal Oncology. 3 (2024) - p. 100039 , 2024
Link:
https://doi.org/10.1016/..
?
4
139P Genomic prognostic and potential theragnostic factors ..:
Hamza, A.
;
Masliah-Planchon, J.
;
Neuzillet, C.
...
ESMO Open. 8 (2023) 1 - p. 101989 , 2023
Link:
https://doi.org/10.1016/..
?
5
ESMO Congress 2021: highlights from the EORTC gastrointesti..:
Koessler, T.
;
Alsina, M.
;
Arnold, D.
...
ESMO Open. 7 (2022) 2 - p. 100392 , 2022
Link:
https://doi.org/10.1016/..
?
6
PO-1263 Exclusive radiotherapy in early stage anal cancer -..:
Briens, A.
;
Neuzillet, C.
;
Huguet, F.
...
Radiotherapy and Oncology. 161 (2021) - p. S1042-S1043 , 2021
Link:
https://doi.org/10.1016/..
?
7
Combining immunotherapy with an epidrug in squamous cell ca..:
de Guillebon, E.
;
Jimenez, M.
;
Mazzarella, L.
...
ESMO Open. 6 (2021) 3 - p. 100106 , 2021
Link:
https://doi.org/10.1016/..
?
8
Translatome-based classification reveals a dual metabolic d..:
Shin, S.
;
Nicolle, R.
;
Jean, C.
...
Pancreatology. 21 (2021) - p. S43 , 2021
Link:
https://doi.org/10.1016/..
?
9
Time from first seen in specialist care to surgery does not..:
Brugel, M.
;
Bouché, O.
;
Kianmanesh, R.
...
BMC Surgery. 21 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
10
Time intervals to diagnosis and chemotherapy do not influen..:
Laurent-Badr, Q.
;
Barbe, C.
;
Brugel, M.
...
Digestive and Liver Disease. 52 (2020) 6 - p. 658-667 , 2020
Link:
https://doi.org/10.1016/..
?
11
2352 Sunitinib as second-line treatment in patients with ad..:
Neuzillet, C.
;
Seitz, J.F.
;
Fartoux, L.
...
European Journal of Cancer. 51 (2015) - p. S452 , 2015
Link:
https://doi.org/10.1016/..
?
12
Is primary tumor resection associated with a longer surviva..:
de Mestier, L.
;
Neuzillet, C.
;
Pozet, A.
...
European Journal of Surgical Oncology (EJSO). 40 (2014) 6 - p. 685-691 , 2014
Link:
https://doi.org/10.1016/..
?
13
Étude multicentrique randomisée d'évaluation d'un programme..:
Neuzillet, C.
;
Vergnault, M.
;
Touillaud, M.
..
Annals of Physical and Rehabilitation Medicine. 56 (2013) - p. e245 , 2013
Link:
https://doi.org/10.1016/..
?
14
Physical activity in patients with unresectable pancreatic ..:
Neuzillet, C.
;
Vergnault, M.
;
Touillaud, M.
..
Annals of Physical and Rehabilitation Medicine. 56 (2013) - p. e247-e248 , 2013
Link:
https://doi.org/10.1016/..
?
15
398 Benchmarking the Allosteric MEK Inhibitors UO126, AZD62..:
Neuzillet, C.
;
Serova, M.
;
Raballand, A.
...
European Journal of Cancer. 48 (2012) - p. 121 , 2012
Link:
https://doi.org/10.1016/..
1-15